Novamind is a leading mental health company enabling safe access to psychedelic medicine through a network of clinics and clinical research sites. Novamind provides ketamine-assisted psychotherapy and other novel treatments through its network of integrative mental health clinics and operates a full-service contract research organization specialized in clinical trials and evidence-based research for psychedelic medicine. For more information on how Novamind is enhancing mental wellness and guiding people through their entire healing journey, visit www.novamind.ca.
Novamind Inc. (NM)
Le 8 novembre/November 2021
Effective immediately, Novamind Inc. will be reinstated for trading.
The Company has rectified the default situation that gave rise to the suspension.
Avec effet immédiat, Novamind Inc. sera réintégré aux fins de négociation.
La Société a rectifié la situation de défaut ayant donné lieu à la suspension.